Patent details

Basic Information

Publication number:

EP1608407

PCT Application Number:

PCT/IB/2004/000826

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047190301

PCT Publication Number:

WO/2004/082588

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DISPERSIBLE FORMULATION OF AN ANTI-INFLAMMATORY AGENT

French Title of Invention:

FORMULATION DISPERSIBLE D'UN AGENT ANTI-INFLAMMATOIRE

German Title of Invention:

DISPERGIERBARE PHARMAZEUTISCHE ZUSAMMENSETZUNG EINES ENTZÜNDUNGSHEMMERS

SPC Number:

Dates

Filing date:

10/03/2004

Grant date:

30/08/2006

EP Publication Date:

30/08/2006

PCT Publication Date:

30/09/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/12/2005

EP B1 Publication Date:

30/08/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/03/2009

Expiration date:

10/03/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/03/2007

 

 

Name:

Pharmacia Corporation

Address:

100 Route 206 North, Peapack, NJ 07977, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/09/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WATTS Jeffrey, L. Pfizer Global Res. and Dev.

Address:

United States (US)

2

Name:

BURNS John, W. Pfizer Global Res. and Dev.

Address:

United States (US)

3

Name:

BRITTEN Nancy, J. Pfizer Global Res, and Dev.

Address:

United States (US)

4

Name:

WALDRON Niki, A. Pfizer Global Res. and Dev.

Address:

United States (US)

5

Name:

HALLBERG John, W. Pfizer Global Res. and Dev.

Address:

United States (US)

Priority

Priority Number:

456325 P

Priority Date:

20/03/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/44;

Filing date	Document type	Number of pages